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CXCR6-GFP+ cells, which encompass 70% invariant natural killer
T cells (iNKT cells), have been found primarily patrolling inside
blood vessels in the liver. Although the iNKT cells fail to interact
with live pathogens, they do respond to bacterial glycolipids pre-
sented by CD1d on liver macrophage that have caught the mi-
crobe. In contrast, in this study using dual laser multichannel
spinning-disk intravital microscopy of joints, the CXCR6-GFP, which
also made up 60–70% iNKT cells, were not found in the vascula-
ture but rather closely apposed to and surrounding the outside of
blood vessels, and to a lesser extent throughout the extravascular
space. These iNKT cells also differed in behavior, responding rapidly
and directly to joint-homing pathogens like Borrelia burgdorferi,
which causes Lyme disease. These iNKT cells interacted with
B. burgdorferi at the vessel wall and disrupted dissemination
attempts by these microbes into joints. Successful penetrance of
B. burgdorferi out of the vasculature and into the joint tissue was
met by a lethal attack by extravascular iNKT cells through a gran-
zyme-dependent pathway, an observation also made in vitro for
iNKT cells from joint but not liver or spleen. These results suggest
a novel, critical extravascular iNKT cell immune surveillance in joints
that functions as a cytotoxic barrier and explains a large increase in
pathogen burden of B. burgdorferi in the joint of iNKT cell-deficient
mice, and perhaps the greater susceptibility of humans to this path-
ogen because of fewer iNKT cells in human joints.
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An essential component of homeostasis is the delivery ofoxygen and nutrients to tissues via an extensive vascular
network. This process, however, also creates a portal for pathogens
to exploit the dissemination of invading bacteria. Intravascular
immunity is an emerging concept that suggests that the host im-
mune system remain vigilant and proactive within the vasculature,
limiting or preventing pathogen dissemination (1). As such, it is not
surprising that numerous cell types have been discovered patrolling
the vasculature, including rolling neutrophils in places like skin,
crawling monocytes (2), and invariant natural killer T cells (iNKT
cells) (3) in skin, brain, muscle, and lung, and immobilized mac-
rophages, including Kupffer cells and splenic macrophage in liver
and spleen, respectively (4). Although macrophage have been
demonstrated to directly catch, phagocytose, and destroy various
pathogens, iNKT cells have to date been suggested to receive
signals via antigen presentation and produce potent cytokines
that can enhance immunity to infections (4–6), but their direct
role in killing pathogens has not been reported. However, it is
worth mentioning a recent publication suggesting that iNKT cells
can produce granzyme B (7), a molecule known to be used by
other immune cells to kill tumor cells as well as various fungi.
The natural killer T cells, a subpopulation of T lymphocytes, ex-
press a T-cell receptor (TCR) with an invariant variable α-segment
14-joining α-segment 18 (Vα14-Jα18) TCR-α chain that is paired
with a restricted subset of TCR Vβ chains in mice (Vα24-Jα18 or
Vβ11 in humans) (5, 6). This highly restricted repertoire of TCRs
expressed by iNKT cells allows them to recognize lipid antigens
presented by CD1d (8, 9), a nonclassical MHC class I-like molecule.
The most potent iNKT antigen identified was α-galactosylceramide
(αGC) (10), and in vivo administration of this molecule leads to
rapid stopping of patrolling iNKT cells with subsequent production
of various cytokines, including IL-4 and IFN-γ (5, 6). More recently,
several lipid antigens from pathogens have been reported, including
α-galactosyl diacylglycerolipid from Borrelia burgdorferi, a spirochete
responsible for human Lyme disease (8, 9, 11–13). Imaging of the
intravascular immune response in vivo to αGC, which would ex-
clusively bind CD1d, has shown a cessation of iNKT cell crawling
and the production of cytokines. Unlike a specific CD1d ligand, an
intact pathogen has many activating molecules, ranging from Toll-
like receptor (TLR) ligands to complement to chemoattractants,
and its direct interaction with iNKT cells is not fully elucidated.
B. burgdorferi is arguably the prototype emerging pathogen,
becoming a global public health concern estimated at as many as
300,000 patients a year in North America (www.cdc.gov/media/
releases/2013/p0819-lyme-disease.html). Lyme disease is one of
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the most common vector-borne diseases and the number of infected
patients is continuing to increase (14). A variety of symptoms have
been identified, the most common late-stage manifestation being
joint inflammation, known as Lyme arthritis (14). In most cases,
treatment with antibiotics leads to resolution of symptoms, but in
the absence of antibiotic therapy, intermittent or chronic synovial
inflammation can occur (14, 15). Although iNKT cells have not
been reported in joints of mice, mice lacking iNKT cells have
a joint-specific 25-fold increase (PCR product) in pathogen burden
in Lyme borreliosis (4, 13). Although it is well appreciated that
iNKT cells receive signals from antigen-presenting cells to induce
a systemic increase in IFN-γ, an important cytokine in the fight
against infection, it is unclear why the absence of this response
would favor localization of B. burgdorferi only in joints (4, 13). We
hypothesized that the iNKT cells were also exerting their protective
effects directly in the knee microvasculature. Indeed, we have
identified a population of CXCR6-GFP+ cells, 60–70% of which
were iNKT cells that resided in the tissues and preferentially sur-
rounding the joint vasculature. These cells performed direct im-
mune surveillance in joints that function as a cytotoxic barrier,
killing pathogens via a granzyme-dependent mechanism. These cells
appear to be less prevalent in human joints and may explain the
greater susceptibility to Lyme borreliosis in these human tissues.
Results and Discussion
Detection and Visualization of Knee Joint iNKT Cells in Mice and Humans.
iNKT cells have been found to be most abundant in the liver, ac-
counting for close to 30% of all immune cells in this organ (16),
with significant numbers in the spleen, lung, and lymph nodes.
Recently, a human study reported iNKT cells in knee joints of
B. burgdorferi-infected patients (17), but their potential role was
unknown. However, when we administered B. burgdorferi to
iNKT cell-deficient mice, they had a 25-fold increase in pathogen
tropism to joints compared with wild-type mice (using PCR),
which have almost undetectable levels of this pathogen. Mean-
while, the liver and other organs show very minor changes in
pathogen burden. In fact, the joint is the only organ to be sig-
nificantly affected by iNKT cell deficiency. We visualized and
compared the distribution of iNKT cells in the liver and knee
joint of CXCR6-GFP mice, in which 60–70% of GFP+ cells are
iNKT cells (3, 4). In the liver, iNKT cells resided exclusively in
the sinusoids (Fig. 1A) and crawled in a random pattern, at times
changing directions 180°, as previously described by us and
others (3, 4). On occasion the cells are swept away by the blood
flow (Movie S1). In contrast, knee joint iNKT cells were not seen
in the vasculature but rather were distributed throughout the
extravascular tissue, with frequent prevalence surrounding blood
vessels and remaining in close, if not intimate contact, with the
microvasculature (Fig. 1 B and C). The iNKT cells were not
uniformly distributed but rather were found predominantly at
the surface of the knee joint (near the capsule and patella ten-
don, where bacteria appeared to adhere, as shown later), with
only a few iNKT cells detected in the tissue located underneath
(Fig. 1C). Unlike in the liver sinusoids, where most of iNKT cells
crawl, 90% of iNKT cells in the joints were stationary (<2.5
μm/min) and less than 10% were seen to be slowly crawling al-
most exclusively near the vasculature (Fig. 1D and Movie S2).
Although surgery can always be a confounding variable in im-
aging, leading to this type of iNKT cell recruitment, it should be
noted that we never saw recruitment of iNKT cells from the
vasculature (they were already there). Despite the fact that sur-
gical preparation of the joint was very minor and lasted less than
5 min, the iNKT cells were already outside the vasculature and not
adhering in the vasculature, suggesting these were resident extra-
vascular iNKT cells. Killing the mouse and fixing tissue before
exposing the joint vasculature still revealed iNKT cells outside not
inside the blood vessels. The extravascular location of these iNKT
cells is further highlighted by 3D reconstructions (Movie S3). The
nonpatrolling-stopped phenotype of the iNKT cells was evident
despite no evidence of any inflammation: the joints and vessel were
devoid of adhering and emigrating neutrophils, a hallmark feature
of inflammation. Using either LysM-EGFP mice (fluorescent
monocytes and neutrophils) or anti-mouse Ly-6G in wild-type mice
(fluorescent neutrophils), we only saw rolling neutrophils with no
neutrophils or monocytes adhering in the joint vessels, suggesting
minimal activation of the preparations (Movie S4).
Not all CXCR6-GFP+ cells are iNKT cells. The CXCR6-GFP
cells that are not iNKT cells have been shown to be other small
subpopulations of T cells (accounting for about 30%). When
transgenic mice with CXCR6-GFP cells were crossed to Vα14-Jα18
TCR-transgenic mice (which have primarily iNKT cells at the ex-
pense of other T cells) and were examined using spinning-disk
microscopy, imaging revealed similar distribution and amount of
CXCR6+ cells around joint vessels, again confirming a large pro-
portion of these cells are iNKT cells (Fig. 1E). Fig. 1F shows the 3D
reconstruction, highlighting the iNKT cells in the extravascular
space, and Fig. 1G demonstrates that the majority of these iNKT
cells are stationary.
Using a new immunohistochemical approach in whole-mount
and frozen knee sections revealed that at least 60–70% of
CXCR6+ cells were costained with the very specific CD1d tet-
ramer that recognizes TCR Vα14i, the specific marker for iNKT
cells (Fig. 2A). Unfortunately, the platelet endothelial cell ad-
hesion molecule-1 (PECAM-1) antibody for mouse endothelium
did not work in frozen sections using immunohistochemistry,
making it hard to see the vasculature. To determine whether
Fig. 1. Extravascular distribution and behavior of iNKT cells in
murine joint tissues. Multichannel fluorescent spinning-disk
confocal microscopy revealed the knee microvasculature of
CXCR6-GFP mice. Representative images showing a character-
ized distribution of CXCR6+ cells in the liver (A) and knee joint
tissue (B). Most of CXCR6+ cells were localized outside the
blood vessel (C) and at the extra-articular vasculature of the
knee joint (n ≥ 3 mice per group). (D) CXCR6+ cell velocity
tracks in the liver and joint microvasculature under normal
conditions. Data are representative of more than three in-
dependent experiments with more than five fields-of-view
(FOVs). (E) Representative images from spinning-disk confocal
intravital microscopy to visualize iNKT cells in the knee joint
tissue of Vα14-Jα18 TCR transgenic (Vα14.Tg) CXCR6-GFP mice
at 5–10 min after killing to demonstrate that iNKT cells were
the predominant cell type surrounding joint vasculature, and
that they were likely there before surgery. Additionally, killing
mice allowed for better 3D reconstruction (F), highlighting the
extravascular distribution of the iNKT cells. (G) The majority of
Vα14.Tg-CXCR6+ cells were stationary in vivo. Data are repre-
sentative of more than two experiments. (Scale bars, 100 μm.)





















a similar distribution occurred in humans, we first analyzed hu-
man synovial biopsies from nonarthritic or mild-arthritic indi-
viduals. Consistent with the detection of iNKT cells in mice,
double-positive cells for CXCR6 and the invariant CDR3 region
of TCR Vα24-Jα18 were found in frozen sections of the anterior
compartment or the suprapatellar pouch of the human synovium
shown in cross-section (Fig. 2B). A cross section reveals that
iNKT cells were found outside the vasculature (antibody against
human PECAM-1 worked in human frozen sections). However,
it is worth noting that there were fewer iNKT cells in human than
mouse joints. To explore whether there were any iNKT cells in
synovial fluid, a costaining analysis with antibodies against human
CD3 and human CD1d-tetramer were used (Fig. 2 C and D).
iNKT cells were barely detectable in the synovial fluid from a pa-
tient who has no arthritis (Fig. 2C). In contrast, iNKT cells were
increased in the synovial fluid from various patients with joint
inflammation, including mildly and severely inflamed joints of
osteoarthritis (OA) patients, rheumatoid arthritis (RA) patients,
and from a patient with Lyme arthritis (Fig. 2C). The iNKT cells
released into the synovial fluid of arthritis and Lyme disease
patients showed higher levels of expression of the activation
marker, CD69, than in normal patients (Fig. 2 D and E). There-
fore, iNKT cells are present in human joints and can increase in
number and activation status in inflammation.
Immune Surveillance by Extravascular iNKT Cells in Joints. To de-
termine the role of resident iNKT cells in the otherwise normal
healthy joint, we focused on a very common infection of joints,
namely the Lyme disease-inducing pathogen, B. burgdorferi.
B. burgdorferi expressing the fluorescent protein GFP or Tomato
was administered to BALB/c, CXCR6-GFP, or Cd1d−/−, mice as
previously reported (4). B. burgdorferi appears as an elongated,
highly motile spirochete, often displaying a to-and-fro motion,
but when the spirochete dies it becomes a rounded, nonmotile
fluorescent particle (confirmed by propidium iodide). Upon in-
travenous injection, the spirochetes adhere to the inner wall of
joint vessels (Fig. 3A and Movie S5). iNKT cells in the vicinity of
the pathogen and abutting the vessel wall interact with the spi-
rochete. It was not unusual to see the spirochete’s tail thrash
(Fig. 3B and Movie S5). The spirochete did eventually appear
outside the vasculature rounded up, nonmotile, and in many
cases dead (Fig. 3C and Movie S5). These observations suggest
that iNKT cells limit the dissemination of B. burgdorferi as they
exit the vasculature, perhaps through direct killing, although the
resolution was not sufficient to conclude direct contact across the
vasculature (Fig. 3 A–C).
Increased Bacterial Dissemination in iNKT Cell-Deficient Mice. Spi-
rochetes adhered equally well to the inner vessel wall in wild-type
and iNKT cell-deficient (Cd1d−/−) mice, and the number of
adherent B. burgdorferi was highest immediately after injection
and was progressively reduced over 3 d in wild-type and Cd1d−/−
mice (Fig. 3D). The disappearance of the spirochetes in blood is
a result of uptake by macrophage in the liver, as we previously
reported (4). As opposed to the liver, where after B. burgdorferi
infection, intravascular iNKT cells became stationary but did not
interact with live B. burgdorferi (4), extravascular iNKT cells in the
knee changed from being stationary and increased their crawling
activity (Fig. 3E and Movie S6) and their crawling velocity (Fig.
3F), but primarily in areas surrounding where B. burgdorferi ad-
hered. In fact, even 100–200 μm away from the adherent patho-
gen, fewer iNKT cells could be seen crawling and more were
adherent (Fig. 3G). The increase in crawling behavior was not
profound with heat-killed B. burgdorferi (Fig. 3H). Interestingly,
the crawling was not restricted to B. burgdorferi but was also seen
with Escherichia coli (Fig. 3I), suggesting perhaps direct detection
by one or multiple pathogen-associated molecular patterns, in-
cluding TLR2 and TLR8 (18, 19), complement, or some other
molecule. Indeed, inhibition of complement (Ecb) resulted in
decreased iNKT cell crawling behavior after infection (Fig. S1).
The iNKT cells also played a role to limit B. burgdorferi in the
tissue. It was not unusual to see a B. burgdorferi in the extravas-
cular space moving around (Fig. 4A, Left) until it interacts with an
iNKT cell, at which point it remains immobilized for duration of
the experiment (Fig. 4A, Right, and Movie S7). In iNKT-deficient
mice, many more B. burgdorferi were found moving around the
tissues, whereas in wild-type mice, more immobile rounded-up
B. burgdorferi were detected (Fig. 4B and Movie S8). Although the
use of Vα14.Tg-CXCR6-GFP mice that only had GFP+ iNKT cells
(very few other T cells) showed similar ability to kill B. burgdorferi as
wild-type mice (Fig. S2), the number of live spirochetes was greatly
enhanced in Cd1d−/− mice at 3 d after B. burgdorferi inoculation
(Fig. 4C), suggesting a critical role of iNKT cells in bacterial killing
as B. burgdorferi traverses the vasculature and enters the joint tissue.
No heat-killed B. burgdorferi were ever found in the knee joint tis-
sue, consistent with an active emigration process by pathogen. We
also bred the GFP+mice with CD1d-deficient mice. These mice still
had green fluorescent cells in the joint, but the cells were smaller in
appearance than the iNKT cells and we never saw these cells
interacting with B. burgdorferi. Not surprisingly, these mice also had
increased burden of B. burgdorferi (Fig. 4D). Indeed, in whole iNKT
cell-deficient joints, a 25-fold increase in PCR product for
B. burgdorferi burden have been reported (4, 13), and herein we
reveal that the PCR product for B. burgdorferi reflects about
a fourfold increase in live bacteria living in joint tissue, normally
eradicated by iNKT cells.
Granzyme-Dependent Bacterial Killing by Joint iNKT Cells. Recogni-
tion of B. burgdorferi in liver by iNKT cells required antigen
presentation on CD1d via macrophages (4). In striking contrast,
blockade of CD1d had no effect on pathogen killing in the knee
vasculature (Fig. 5A), despite direct intra-articular injection of
this antibody, an approach that inhibits function of other cells
Fig. 2. Detection of iNKT cells in mouse and human knee joint synovium.
(A) Representative images showing most CXCR6+ cells are CD1d-tetramer+ in
the knee joint tissue. Ten-micrometer frozen sections of CXCR6-GFP mouse
knee joint were labeled with PBS57-loaded CD1d-tetramer. (B) Immunohis-
tochemical analysis of frozen human synovial membrane. Ten-micrometer
frozen synovium sections of nonarthritic membrane were labeled with anti-
human TCR Vα24-Jα18 (green) and anti-human CXCR6 (red). In A and B, data
are representative of more than two experiments. (C) The absolute number
of iNKT cells in synovial fluid from normal individuals (n = 2) and patients
with OA (n = 1 for mild; n = 3 for severe), RA (n = 2), or Lyme arthritis (LA,
n = 1). Error bars, SEM. The CD69 expression of CD3+CD1-tet+ iNKT cells in
peripheral blood (gray) and synovial fluid from mild (blue) and severe (red)
OA patients (D), and from a Lyme arthritis patient (CD3–CD1-tet–, black;
CD3+CD1-tet–, blue; CD3+CD1-tet+, red) (E). (Scale bars, 100 μm.)
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using other antibodies. It is worth noting that the iNKT cells
could respond to antigen loaded on CD1d to produce IFN-γ
(either αGC or B. burgdorferi) (Fig. S3). However, this process
does not appear to kill B. burgdorferi in joints. To determine
whether there was direct killing of B. burgdorferi by iNKT cells,
CXCR6+ cells were isolated from different tissues and coincu-
bated with fluorescent B. burgdorferi, and the viability of the
spirochetes was determined at 48 h after incubation. Notably,
and as illustrated in Fig. 5B, coincubation of joint CXCR6+ cells
with B. burgdorferi resulted in a significant decrease in the
number of active bacteria, whereas the cells from liver and
spleen were unable to display the lethal activity. In fact, even
five-times greater concentrations of CXCR6+ cells from liver and
spleen did not show any significant killing activity. It was ex-
tremely difficult to get pure iNKT cells from joints because of the
limited numbers and additional steps of isolating pure joint
iNKT cells. Nevertheless, a few experiments revealed significant
killing capacity by purified joint but not liver or spleen iNKT
cells (Fig. 5C). The reduced killing could be because of reduced
function of the iNKT cells as a result of increased isolation steps
or another cell type that also helps to kill. Regardless, a pure
population of joint iNKT cells can kill B. burgdorferi. One dif-
ference between liver and joint iNKT cells was predominantely
CD4+ iNKT cells in the liver and CD4– iNKT cells in the
joint (Fig. S4).
Previous reports have shown that human iNKT cells do harbor
some NK-like cytolytic molecules, including granzyme and per-
forin (20), and a recent study has identified HOBIT (homolog of
Blimp-1 in T cells, Znf683) as a transcriptional program for
granzyme in mature iNKT cells that have returned back to thy-
mus but not spleen or liver (7). Therefore, we next investigated
how iNKT cells mediate the spirochete cell death and observed
a Ca2+-dependent killing mechanism (EGTA inhibitable) (Fig.
5D) (21). A serine protease inhibitor 3,4-dichloroisocoumarin
(DCI) that blocks granzyme (22), and to a much lesser extent a
vacuolar ATPase inhibitor concanamycin A (CMA) that blocks
perforin (23), prevented killing of B. burgdorferi (Fig. 5D). This
finding indicated that iNKT cells in joint tissue kill using pri-
marily the granzyme pathway. To further demonstrate this direct
killing in vivo via granzyme, mice lacking this molecule also had
increased B. burgdorferi in joints (Fig. 5E). We also stained the
iNKT cells from joints and identified very significant increases in
granzyme B, but not granzyme A, staining and CD69 activation
following B. burgdorferi infection (Fig. 5F and Fig. S5).
The use of multichannel-fluorescence spinning-disk micros-
copy in vivo has directly demonstrated the existence of iNKT
cells in the joint tissue juxtaposed around microcirculatory ves-
sels and throughout the interstitium, where they play a critical
role in limiting B. burgdorferi entry into the joint of mice and
killing B. burgdorferi in the tissue. Although it was well known
that iNKT cell-deficient mice have huge B. burgdorferi burdens
almost exclusively in joints (4), the existence of iNKT cells in
joints was previously undetected, perhaps because of their dis-
tribution around the sparse vasculature. We also detected
Fig. 3. Extravascular immune surveillance provided by joint iNKT cells in
B. burgdorferi infection. The knee joint microvasculature of CXCR6-GFP mouse
was visualized and recorded for 2.5 h after Tomato-expressing B. burgdorferi
injection to observe the interaction of iNKT cells, endothelium, and spirochetes.
Endothelium was stained with Alexa Fluor 647 anti-mouse PECAM-1. Repre-
sentative images showing an (A) adhering spirochete that (B) 30-min later was
still alive and appearing to thrash, whereas (C) 1 h and 45 min later the spi-
rochete has moved out of the vasculature but is round immobile. A yellow
arrow points to the spirochete. (Scale bars, 50 μm.) (D) At 1 h, 2 h, 6 h, 1 d, and
3 d after GFP- or Tomato-expressing B. burgdorferi injection (intravenous), the
number of spirochetes (per FOV) adhered to endothelium was measured in
wild-type (BALB/c) or iNKT cell-deficient (Cd1d−/−) mouse knee joint vasculature
using spinning-disk confocal intravital microscopy (n ≥ 3 individual mice per
group; error bars, SEM). (E) Alteration in extracellular iNKT cell behavior after
B. burgdorferi infection. The number of adherent and crawling iNKT cells at
1‒3 h postinfection was compared with noninfection control. (F) The average
crawling velocity of all cells in the FOV increased. (G) Crawling velocity of iNKT
cells at 0‒100 μm and at 100–200 μm from adhered B. burgdorferi. (In E–G, iNKT
cell tracks less than 1 μm/min were considered as adherent; n ≥ 3 mice per
group). Extracelular iNKT cell velocity in response to either (H) at 1‒3 h after
heat-killed B. burgdorferi or (I) 1–3 h after E. coli. Data are representative of two
experiments. *P < 0.05 or **P < 0.01 vs. noninfected control (‒B. burgdorferi) by
t test (in E and F) and vs. 0‒100 μm (in G). Error bars, SEM.
Fig. 4. iNKT cells are critical in the defense against B. burgdorferi dissemi-
nation into the joint tissue. (A) Representative images showing extravasated
B. burgdorferi in CXCR6-GFP mouse joint at 1 h after infection. (Left) Yellow
and red arrowheads denote a stationary iNKT cell and a motile B. burgdorferi
in an extravascular space, respectively. (Right) The B. burgdorferi is captured
by the iNKT cell. A dotted red arrow denotes the crawling route of the
B. burgdorferi. Captured B. burgdorferi remained immobile for duration of
the experiment (an additional hour). (Scale bar, 50 μm.) (B) Representative
images showing that most GFP-expressing particles outside vasculature were
round and nonmotile in wild-type knee joint (Left) and many intact and
motile GFP-expressing spirochetes were infiltrated to outside vasculature at
3 d postinfection in the Cd1d−/− knee joint (Right). (Scale bar, 100 μm.) (C and D)
The number of intact/active mobile spirochetes in wild-type (or CXCR6-GFP)
and Cd1d−/− (or Cd1d−/−CXCR6-GFP) knee joints at 3 d after B. burgdorferi
infection was measured (n ≥ 3 mice per group). *P < 0.05, **P < 0.01 vs. wild-
type (or CXCR6-GFP) by t test. Error bars, SEM.





















iNKT cells in human joints, although fewer than seen in mice,
perhaps explaining the striking Lyme arthritis in humans but not
in infected rodents. Although iNKT cells are visualized in the
vasculature of the liver, spleen, and lung (3, 4, 24, 25), a resident
blood population of iNKT cells was not observed in the joint
vasculature. Moreover, whereas iNKT cells in liver responded to
B. burgdorferi via CD1d on antigen-presenting cells, inhibition
of CD1d had no effect on the host response of iNKT cells in
the joints. In fact, unlike iNKT cells in liver, which were unable
to recognize live B. burgdorferi, joint iNKT cells actively parti-
cipated in spirochete clearance through a direct bactericidal
granzyme-mediated pathway, something neither splenic nor
liver iNKT cells could do, even in vitro in direct contact with
B. burgdorferi. This finding aligns well with the recent publication
that a transcription factor BLIMP is turned on in iNKT cells in
some tissues but not in the liver or spleen, to allow for the pro-
duction of granzyme B and other effector mechanisms (7). These
differences in iNKT cells in different organs are reminiscent of
organ-specific macrophage (Kupffer cells vs. microglia vs. splenic
macrophage) and mast cells (mucosal vs. connective tissue).
Using imaging revealed an important barrier function for
iNKT cells, and in their absence, B. burgdorferi gained easy ac-
cess into the joint. How the pathogens are recognized by iNKT
cells in joints is not clear but we speculate that opsonins, TLRs,
or other pattern-recognition molecules may be involved. Indeed,
blocking complement reduced the searching/crawling activity of
iNKT cells, suggesting opsinization of B. burgdorferi, and shed
complement fragments must leak into the extravascular space to
alert the iNKT cells to the presence of these pathogens (26).
Interestingly, we observed similar results after injecting E. coli,
consistent with broad pathogen-associated molecular pattern
detection (such as complement) rather than exclusive CD1d an-
tigen presentation. Clearly, this study highlights the importance of
iNKT cell positioning around the vasculature and in the inter-
stitium of the joint, revealing their unique cytolytic activity and
raising the possibility that increasing iNKT cell numbers or ac-
tivity in joint could increase immunity against B. burgdorferi.
Materials and Methods
Mice. C57BL/6 (B6), BALB/c, 129X1, Cd1d−/−, B6.CXCR6-GFP knock-in, Vα14-Jα18
transgenic, and Gzma−/−Gzmb−/− mice were purchased from The Jackson
Laboratory. CXCR6-GFP knock-in mice on the BALB/c background were a gift
from Dan R. Littman (New York University School of Medicine, New York).
Cd1d−/−CXCR6-GFP mice were made by crossing Cd1d−/−Cxcr6gfp/gfp with
Cd1d−/−Cxcr6+/+ mice. Mice were maintained in a specific pathogen-free,
double-barrier unit at the University of Calgary. All protocols used were in
accordance with the guidelines drafted by the University of Calgary Animal
Care Committee and the Canadian Council on the Use of Laboratory Animals.
Human Subjects. Patients with OA (n = 1, male age: 59 for mild OA; n = 3,
2 males age: 35 and 66; 1 female age: 55 for severe OA; Ethics ID #21987) and
RA (n = 2, females age: 31, 40; Ethics ID #24270) with no other comorbidities
consented to arthrocentesis and had synovial fluid aspirated from their
knees (volume 5 mL, 20.3 mL ± 6.4 mL and 34.5 mL ± 6.5 mL per recovered
knee of mild OA, severe OA, and RA patients, respectively) during a visit to
the University of Calgary Foothills Medical Clinic. Synovial fluid from mac-
roscopically normal knees was aspirated from cadavers less than 4 h after
death (Ethics ID #21987). Lyme disease patient samples had to be obtained
from the Northeast of the United States and were not available in western
Canada. Synovial fluid from a Lyme arthritis patient was collected on Na-
tional Institutes of Health, National Institute of Allergy and Infectious Dis-
ease under Institutional Review Board-approved protocol 02-I-0055 (n = 1,
male age: 65). Synovial fluid from patients treated with any immunosup-
pressive drugs was excluded.
Intravital Microscopy of the Knee Joint.Murine joint intravital microscopy was
performed as previously described (27). Briefly, the jugular vein of the
anesthetized mice was cannulated to administer fluorochrome-labeled
antibodies and additional anesthetic solution as required. Mice were placed
in dorsal recumbency on a heating plate (CU-201, Live Cell Instruments) and
body temperature was maintained at 37 °C. The skin and connective tissue
over the right knee were surgically removed to expose the anteriomedial
aspect of the knee joint and the exposed knee joint was immediately and
continuously perfused with warmed buffer (134 mM NaCl, 20 mM NaHCO3,
4.7 mM KCl, 1.2 mM MgSO4, pH 7.4) at a rate of 10 mL/h using a peristaltic
pump (Gilson). The mouse was placed on a suitable stage for knee joint
intravital microscopy and a glass coverslip was gently placed over the medial
aspect of the knee joint with vacuum grease.
Spinning-Disk Confocal Microscopy of the Liver and Knee Joint Tissues. Multi-
channel fluorescence intravital microscopy of mouse liver and knee joint was
done as previously described (4, 27–29). CXCR6-GFP mice were used for the
visualization of hepatic and knee joint iNKT cells (3, 4). Anti-mouse PECAM-1
(clone 390; eBioscience) was used for delineation of the joint vasculature.
The activity of iNKT cells and bacteria in the knee joint vasculature was
assessed simultaneously with three laser-excitation wavelengths in rapid
succession (491 nm, 561 nm, and 635 nm; Cobolt) and was visualized with the
appropriate band-pass filters (Semrock). Typical exposure time for excitation
wavelengths was 0.5–0.7 s. A back-thinned electron-multiplying charge-cou-
pled device camera (C9100-13, Hamamatsu) was used for fluorescence de-
tection. Volocity software (Improvision) was used for acquisition and analysis
of images.
Bacterial Strain and Treatment of Mice. The GFP (pTM61) and Tomato (pTM201)
expression plasmids were constructed as previously described (28). All
B. burgdorferi strains were grown for 48 h in BSK-II medium prepared in-
house (30) in the presence of 1% (vol/vol) mouse blood (28). For the gener-
ation of B. burgdorferi strains GCB776 (infectious Tomato), electrocompetent
infectious B. burgdorferi were prepared from strain B31 5A4 NP1 (31) as
previously described (28). The construction of B. burgdorferi strain GCB726
(infectious GFP) was also previously reported (28). Mice were intravenously
infected via the tail or jugular vein with a dose of 2 or 3 × 108 because it
permitted the observation of the interaction of substantial numbers of
B. burgdorferi in the joint vasculature. For selective blockade of CD1d, 50 μg
Fig. 5. Direct bactericidal activity provided by joint iNKT cells is granzyme
(Gzm)-dependent. (A) Effect of anti-CD1d antibody on the clearance of
B. burgdorferi (“B.”) spirochetes in knee joint tissue (n ≥ 3 mice per group).
(B) Cytotoxic effect of CXCR6+ cells derived from the liver, spleen, or joint
tissue on Tomato-expressing B. burgdorferi. (C) Cytotoxic effect of purified
iNKT cells (requiring additional steps) derived from the liver or joint tissue on
Tomato-expressing B. burgdorferi. (D) The effect of CMA, DCI, or EGTA on
iNKT cell cytotoxicity. Tomato-expressing B. burgdorferi (5 × 103 per milli-
liter) were incubated with CXCR6+ (B) or CXCR6+TCR-β+ (C and D) cells derived
from liver, spleen, or joint at an E:T ratio of 10:1–50:1 at 37 °C and 5% CO2.
The number of surviving B. burgdorferi was counted using hemocytometer
and spinning-disk confocal microscopy system at 2 d after incubation. CMA,
DCI, or EGTA was pretreated with the coculture (n ≥ 5 FOVs per group).
**P < 0.01, *P < 0.05 vs. target cells alone (B and C) or vehicle-treated control
(D) by Bonferroni’s multiple-comparison test. Error bars, SEM. (E) The number of
intact/active mobile spirochetes in wild-type and Gzma−/−Gzmb−/− knee joints at
3 d after B. burgdorferi infection was measured (n ≥ 3 mice per group). *P <
0.05 vs. WT by t test. Error bars, SEM. (F) Gzm expression of GFP+ cells in CXCR6-
GFP and Cd1d−/−CXCR6-GFP mouse joints. Gzm A- or B-expressed cells were
analyzed by flow cytometry at 0 d and 3 d after B. burgdorferi infection. *P <
0.05 vs. before infection, +P < 0.05 vs. CXCR6-GFP by t test. Error bars, SEM.
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anti-mouse CD1d (1B1; eBioscience) was intravenously injected 30 min before
and 2 d after B. burgdorferi injection (4, 32).
Immunohistochemical Analysis for iNKT Cells. Frozen OCT-embedded knee
sections of CXCR6-GFP mice were used for the identification of iNKT cells. For
the immunofluorescence analysis, 10-μm tissue sections were obtained and
incubated overnight at 4 °C with PE PBS57-loaded murine CD1d-tetramer
(National Institutes of Health Tetramer Facility) and Alexa Fluor 647 anti-
mouse CD31 (clone 390; BD Pharmigen) at 1:1,000 dilution.
For human studies, knee synovium samples were obtained from patients
with no or mild arthritis. These samples were also OCT-embedded and fresh-
frozen, and used for the identification of double Vα24-Jα18 TCR and CXCR6
colocalization. Ten-micrometer tissue sections were obtained and incubated
overnight at 4 °C with PE anti-human CXCR6 (clone 56811; R&D systems),
FITC anti-human TCR Vα24-Jα18 (clone 6B11; BD Pharmigen), and Alexa Fluor
647 anti-human CD31 (clone WM59; BD Pharmigen) at 1:200 dilution.
Samples were visualized using a spinning-disk confocal microscope.
Isolation of iNKT Cells and Cytotoxicity Assay. Liver-, spleen-, and joint-derived
lymphocytes were isolated from CXCR6-GFP mice using a method previously
described (4, 33, 34), with a slight modification. Briefly, livers and spleens
were excised and finely minced in a digestive medium containing 0.05%
collagenase type IV (Worthington Biomedical) and 0.002% DNase I in HBSS.
Joint tissues from mouse hind knees and ankles were placed into Petri dishes
containing 5-mL digestion buffer containing 0.1% collagenase type IV,
0.002% DNase I and 5% (vol/vol) FCS. After gentle agitation at 37 °C for
30 min (for liver and spleen) and 2 h (for joint tissues), the concentrate was
passed through 100-μm and 40-μm cell strainers. The cell suspension was
washed with ice-cold PBS (pH 7.4) and centrifuged at 300 × g for 10 min.
Mononuclear cells were purified by a 40%/70% (vol/vol) Percoll gradient and
were negatively selected with anti-mouse Gr-1 (RB6-8C5; eBioscience), anti-
mouse F4/80, anti-mouse CD19 (1D3; eBioscience), and anti-mouse CD8a (53-
6.7; eBioscience) microbeads and MACS column to remove neutrophils, mac-
rophages, B cells, and CD8a+ cells, respectively. CXCR6-GFP+ or TCR-β+GFP+
(iNKT) cells from 5 to 6 mice were sorted. CXCR6-GFP+ cells or iNKT cells were
resuspended in RPMI medium containing 20% (vol/vol) FCS, 100 U/mL peni-
cillin, and 100 μg/mL streptomycin.
Tomato-expressing B. burgdorferi (GCB776, 5 × 103 cells/mL) were in-
cubated with CXCR6+ cells or iNKT cells at an effector cell:target cell (E:T)
ratio of 10:1–50:1 at 37 °C and 5% CO2. Because the B. burgdorferi strain
used is streptomycin- and penicillin-sensitive, but gentamicin-insensitive, the
cells were incubated in RPMI medium containing 20% (vol/vol) FCS and
50 μg/mL gentamicin. The cells were placed in a 96-well U-shape bottom cul-
ture plate for the experiment. The viability of B. burgdorferi was not altered
at least for 48 h. For some experiments, iNKT cells were treated with 10 nM
CMA (Sigma-Aldrich), 50 μM DCI (Sigma-Aldrich), or 2 mM EGTA (Sigma-
Aldrich). The number of B. burgdorferi survived per well was determined at
48 h after incubation using hemocytometer and spinning-disk confocal
fluorescent microscopy. The inhibitory effect derived by CMA, DCI, and EGTA
was standardized by inhibitor alone group (without iNKT cells).
Flow Cytometry for Human Synovial Fluid. Synovial fluids from patients with
no, mild, or severe arthritis were washed with cold PBS and centrifuged at
50 × g for 20 min at 4 °C. The resuspended cells were filtered by a 100-μm cell
strainer. Cells were incubated with PerCP-Cy5.5 anti-human CD3 (clone OKT3,
eBioscience), PE anti-human PBS57-loaded human CD1d tetramer (National
Institutes of Health) and FITC anti-human CD69 (clone FN50; eBioscience). All
samples were analyzed on an Attune acoustic focusing cytometer (Applied
Biosystems) or BD FACScan system (BD Biosciences).
Statistical Analyses. All values were expressed as mean ± SEM. Data were
compared either by unpaired two-tailed Student t test or one-way ANOVA
with Bonferroni multiple comparisons post hoc test. Statistical significance
was accepted at P < 0.05.
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